Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq analysis of RNA polymerase I inhibitor in p53 null HCT116 colon adenocarcinoma cells.

ABSTRACT: RNA-seq analysis of RNA polymerase I inhibitor in p53 null HCT116 colon adenocarcinoma cells.

PROVIDER: PRJNA1111745 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29029373_1.fastq.gz	Fastqsanger.gz
	SRR29029373_2.fastq.gz	Fastqsanger.gz
	SRR29029374_1.fastq.gz	Fastqsanger.gz
	SRR29029374_2.fastq.gz	Fastqsanger.gz
	SRR29029375_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

RNA-seq analysis of RNA polymerase I inhibitor in p53 null HCT116 colon adenocarcinoma cells.

Project description:Ribosome biosynthesis is essential for cancer growth and proliferation. This dependency is therapeutically exploitable by blocking the rate-limiting step, RNA polymerase I (Pol I) transcription. Here we investigated the effects of RNA Pol I inhibitor on expression of mRNA genes.

2025-05-13 | GSE267502 | GEO

RNA-seq analysis of RNA polymerase I inhibitor in p53 proficient HCT116 colon adenocarcinoma cells

Project description:RNA-seq analysis of RNA polymerase I inhibitor in p53 proficient HCT116 colon adenocarcinoma cells

| PRJNA1111738 | ENA

Gene expression profiling of CYC116 and ZM447439 resistant HCT116 wild type and HCT116 p53 null clones in comparison to parent cell lines

Project description:HCT116 and HCT116 p53 null were exposed to two Aurora kinase inhibitors (CYC116 and ZM447439) at cytotoxic concentrations. Within 4-5 weeks we were able to select and isolate 10 drug resistant clones from each group. 3 clones were selected for gene expression profiling using Affymetrix microarrays (Human Gene 1.0 ST Array). The samples in each group were initially given the code names as follows. Group 1. [R1.3, R4.2, R6.3: CYC116 p53 wild type], Group 2. [R8.7, R9.7, R10.7:CYC116 p53 null], Group 3. [R7.1, R15.1, R16.1:ZM447439 p53 wild type], and Group 4. [R1.5, R3.5, R4.5:ZM447439 p53 null). For publication purpose the names were later changed to, Group 1. [R1.1, R1.2, R1.3: CYC116 p53 wild type], Group 2. [R2.1, R2.2, R2.3:CYC116 p53 null], Group 3. [R3.1, R3.2, R3.3:ZM447439 p53 wild type], and Group 4. [R4.1, R4.2, R4.3:ZM447439 p53 null].

2012-04-01 | E-MEXP-3526 | biostudies-arrayexpress

RNA-seq analysis of RNA polymerase I inhibitor in p53 proficient HCT116 colon adenocarcinoma cells

2025-05-13 | GSE267501 | GEO

Identification of p53-regulated genes in wild-type p53 or p53-null HCT116 cells

Project description:Microarray-based gene expression analysis of HCT116 p53+/+ and HCT116 p53−/− treated with doxorubicin to activate p53 in time-dependent manner.

2019-01-29 | GSE125787 | GEO

Identification of p53-regulated genes in wild-type p53 or p53-null HCT116 cells

Project description:Identification of p53-regulated genes in wild-type p53 or p53-null HCT116 cells

| PRJNA517505 | ENA

RNA-seq of depletion Mina53 in HCT116 p53+/+ cells and HCT116 p53-/- cells

Project description:We report the signaling pathway of Mina53 by depleting Mina53 in HCT116 p53+/+ cells and HCT116 p53-/- cells based on RNA-sequencing.

2024-12-01 | GSE214730 | GEO

Transcription profiling by array of human colorectal cancer epithelial (HCT116) p53 null cells treated with SN38 for 6, 12 and 24h

Project description:HCT116 p53 null cells were treated with 5nM SN38 (active metabolite of CPT-11) for 6, 12 and 24h. Following this RNA was harvested for transcriptional profiling.

2007-11-30 | E-MEXP-1194 | biostudies-arrayexpress

Identification of a STAT2 transcriptome in HCT116 p53 null tumor xenografts

Project description:Identification of a STAT2 transcriptome in HCT116 p53 null tumor xenografts

| PRJNA564684 | ENA

RNA-seq of depletion Mina53 in HCT116 p53+/+ cells and HCT116 p53-/- cells

Project description:RNA-seq of depletion Mina53 in HCT116 p53+/+ cells and HCT116 p53-/- cells

| PRJNA886961 | ENA